We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Myriad cGMP Lapses Found During FDA Inspection of API Maker
Myriad cGMP Lapses Found During FDA Inspection of API Maker
Fourteen days of FDA inspection of its New Brunswick, N.J., facility in February and March earned Spectrum Laboratory Products a 483 describing yellow streaks on floors, peeling paint on walls and only 58 of 5,679 complaints investigated, among the 14 observations in the FDA’s report.